OVERVIEW

Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents is organized by Evolve Medical Education (EME) LLC .

Release Date: Dec 03, 2021
Expiry Date: Nov 28, 2024

Learning Objectives:
Upon completion of this activity, the participant should be able to:

Describe the mechanisms of action of novel therapeutics and classes of drugs for ocular hypertension (OHT) and primary open angle glaucoma (POAG)
Interpret the challenges and limitations associated with currently available pharmacologic treatment options for OHT and POAG
Evaluate monotherapy and combination regimens and compare which option is most likely to achieve each individual patient’s goal IOP
Compare and assess the efficacy of novel therapeutics with traditional prostaglandins

Credits

Accreditation and Designation Statement:
This educational activity is provided by Evolve Medical Education LLC (Evolve).

Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1 AMA PRA Category 1 Credit™
  • TARGET AUDIENCE

    OptometristOphthalmologist

    SPECIALITIES

    OphthalmologyOptometry

    RELATED ONLINE COURSES

    Webcast

    Ophthalmology
    2.5 AAPA
    More actions
    US$299

    Webcast

    Emergency Medicine
    More actions
    US$200

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910